{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:52:08Z","timestamp":1760953928398},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head Face Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>As a tumor-accelerating transcriptional factor, E2F transcription factor 7 (E2F7) was up-regulated in many forms of cancers. Nevertheless, little has been reported about the impacts of E2F7 on oral squamous cell carcinoma (OSCC). Here, we aimed to probe whether E2F7 had influences on OSCC and its potential mechanism.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression of E2F7 in OSCC tissues was analyzed using the data acquired from TCGA and ONCOMINE databases. E2F7 prognostic value in OSCC patients was analyzed utilizing TCGA database. The expression of E2F7 in OSCC cell lines was detected by qRT-PCR. Gain-and loss-function of E2F7 assays in TCA-83 and CAL27 cells were performed respectively to inquire the function of E2F7. Western blotting was applied to test the alternations of EMT-related markers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In OSCC tissues, E2F7 was highly expressed. Besides, high expression of E2F7 predicted worse prognosis in OSCC patients. Moreover, E2F7 was over-expressed in TCA-83, HSC-4 and CAL27 (all OSCC cell lines) cells relative to that in HNOK (a normal cell line) cells. Gain-and loss-function assays displayed that deficiency of E2F7 suppresses CAL27 cell growth, migration, invasion and E2F7 high-expression resulted in inverse outcomes in TCA-83 cells. Finally, we found that silencing of E2F7 facilitated E-cadherin protein expression level and reduced N-cadherin, Vimentin and Snail protein levels in CAL27 cells, whilst E2F7 high-expression exhibited the opposite effects in TCA-83 cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These outcomes indicated that E2F7 performs a carcinogenic role in OSCC, which provides a theoretical basis for the therapeutic strategies of OSCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13005-021-00258-2","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T07:04:02Z","timestamp":1614323042000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of E2F transcription factor 7 as a novel potential biomarker for oral squamous cell carcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Ping","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"key":"258_CR1","doi-asserted-by":"crossref","unstructured":"Malik UU, Siddiqui IA, Ilyas A, Hashim Z, Staunton L, Kwasnik A, et al. Identification of differentially expressed proteins from smokeless tobacco addicted patients suffering from Oral squamous cell carcinoma. Pathol Oncol Res. 2020;26(3):1489\u201397.","DOI":"10.1007\/s12253-019-00724-y"},{"key":"258_CR2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.3389\/fonc.2019.00728","volume":"9","author":"BK Velmurugan","year":"2019","unstructured":"Velmurugan BK, Yeh KT, Hsieh MJ, Yeh CM, Lin CC, Kao CY, et al. UNC13C suppress tumor progression via inhibiting EMT pathway and improves survival in Oral squamous cell carcinoma. Front Oncol. 2019;9:728.","journal-title":"Front Oncol"},{"issue":"6","key":"258_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"258_CR4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s13402-019-00437-z","volume":"42","author":"CP Gan","year":"2019","unstructured":"Gan CP, Sam KK, Yee PS, Zainal NS, Lee BKB, Abdul Rahman ZA, et al. IFITM3 knockdown reduces the expression of CCND1 and CDK4 and suppresses the growth of oral squamous cell carcinoma cells. Cell Oncol (Dordr). 2019;42(4):477\u201390.","journal-title":"Cell Oncol (Dordr)"},{"issue":"6","key":"258_CR5","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1002\/hed.25640","volume":"41","author":"CJ Yen","year":"2019","unstructured":"Yen CJ, Tsou HH, Hsieh CY, Chu CY, Chiu CF, Chen CC, et al. Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: final analysis of a phase 2 clinical trial. Head Neck. 2019;41(6):1703\u201312.","journal-title":"Head Neck"},{"key":"258_CR6","doi-asserted-by":"crossref","unstructured":"Yang Z, Liang X, Fu Y, Liu Y, Zheng L, Liu F, et al. Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma. EBioMedicine. 2019;47:44\u201357.","DOI":"10.1016\/j.ebiom.2019.08.013"},{"issue":"5","key":"258_CR7","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1158\/0008-5472.CAN-08-2725","volume":"69","author":"L Endo-Munoz","year":"2009","unstructured":"Endo-Munoz L, Dahler A, Teakle N, Rickwood D, Hazar-Rethinam M, Abdul-Jabbar I, et al. E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation. Cancer Res. 2009;69(5):1800\u20138.","journal-title":"Cancer Res"},{"issue":"6","key":"258_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19(6):326\u201338.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"258_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ghir.2014.04.003","volume":"24","author":"X Zhi","year":"2014","unstructured":"Zhi X, Lamperska K, Golusinski P, Schork NJ, Luczewski L, Golusinski W, et al. Expression levels of insulin-like growth factors 1 and 2 in head and neck squamous cell carcinoma. Growth Hormon IGF Res. 2014;24(4):137\u201341.","journal-title":"Growth Hormon IGF Res"},{"issue":"4","key":"258_CR10","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/mc.22595","volume":"56","author":"Y Li","year":"2017","unstructured":"Li Y, Sturgis EM, Zhu L, Cao X, Wei Q, Zhang H, et al. E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx. Mol Carcinog. 2017;56(4):1335\u201343.","journal-title":"Mol Carcinog"},{"issue":"9","key":"258_CR11","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3390\/jcm8091454","volume":"8","author":"CH Lin","year":"2019","unstructured":"Lin CH, Lee HH, Kuei CH, Lin HY, Lu LS, Lee FP, et al. Nicotinic Acetylcholine Receptor Subunit Alpha-5 Promotes Radioresistance via Recruiting E2F Activity in Oral Squamous Cell Carcinoma. J Clin Med. 2019;8(9):1454.","journal-title":"J Clin Med"},{"key":"258_CR12","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.biopha.2018.08.099","volume":"107","author":"R Liang","year":"2018","unstructured":"Liang R, Xiao G, Wang M, Li X, Li Y, Hui Z, et al. SNHG6 functions as a competing endogenous RNA to regulate E2F7 expression by sponging miR-26a-5p in lung adenocarcinoma. Biomed Pharmacother. 2018;107:1434\u201346.","journal-title":"Biomed Pharmacother"},{"key":"258_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jocn.2016.04.019","volume":"33","author":"W Yin","year":"2016","unstructured":"Yin W, Wang B, Ding M, Huo Y, Hu H, Cai R, et al. Elevated E2F7 expression predicts poor prognosis in human patients with gliomas. J Clin Neurosci. 2016;33:187\u201393.","journal-title":"J Clin Neurosci"},{"issue":"8","key":"258_CR14","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/s41388-018-0494-7","volume":"38","author":"S Xiang","year":"2019","unstructured":"Xiang S, Wang Z, Ye Y, Zhang F, Li H, Yang Y, et al. E2F1 and E2F7 differentially regulate KPNA2 to promote the development of gallbladder cancer. Oncogene. 2019;38(8):1269\u201381.","journal-title":"Oncogene."},{"issue":"1","key":"258_CR15","first-page":"209","volume":"18","author":"H Guo","year":"2019","unstructured":"Guo H, Zhang L. MicroRNA-30a suppresses papillary thyroid cancer cell proliferation, migration and invasion by directly targeting E2F7. Exp Ther Med. 2019;18(1):209\u201315.","journal-title":"Exp Ther Med"},{"issue":"4","key":"258_CR16","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00404-018-5007-y","volume":"299","author":"S Zong","year":"2019","unstructured":"Zong S, Liu X, Zhou N, Yue Y. E2F7, EREG, miR-451a and miR-106b-5p are associated with the cervical cancer development. Arch Gynecol Obstet. 2019;299(4):1089\u201398.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"258_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrm.2016.8","volume":"17","author":"K Takahashi","year":"2016","unstructured":"Takahashi K, Yamanaka S. A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol. 2016;17(3):183\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"258_CR18","doi-asserted-by":"publisher","first-page":"8947","DOI":"10.3390\/ijms12128947","volume":"12","author":"M Hazar-Rethinam","year":"2011","unstructured":"Hazar-Rethinam M, Endo-Munoz L, Gannon O, Saunders N. The role of the E2F transcription factor family in UV-induced apoptosis. Int J Mol Sci. 2011;12(12):8947\u201360.","journal-title":"Int J Mol Sci"},{"issue":"34","key":"258_CR19","doi-asserted-by":"publisher","first-page":"24581","DOI":"10.1074\/jbc.M113.467506","volume":"288","author":"B Liu","year":"2013","unstructured":"Liu B, Shats I, Angus SP, Gatza ML, Nevins JR. Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression. J Biol Chem. 2013;288(34):24581\u20139.","journal-title":"J Biol Chem"},{"issue":"23","key":"258_CR20","doi-asserted-by":"publisher","first-page":"6289","DOI":"10.1093\/emboj\/cdg613","volume":"22","author":"L Di Stefano","year":"2003","unstructured":"Di Stefano L, Jensen MR, Helin K. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. EMBO J. 2003;22(23):6289\u201398.","journal-title":"EMBO J"},{"issue":"2","key":"258_CR21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bbrc.2019.04.131","volume":"514","author":"Q Cheng","year":"2019","unstructured":"Cheng Q, Cao X, Xue L, Xia L, Xu Y. CircPRKCI-miR-545\/589-E2F7 axis dysregulation mediates hydrogen peroxide-induced neuronal cell injury. Biochem Biophys Res Commun. 2019;514(2):428\u201335.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"258_CR22","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1158\/0008-5472.CAN-17-2808","volume":"78","author":"M Qiu","year":"2018","unstructured":"Qiu M, Xia W, Chen R, Wang S, Xu Y, Ma Z, et al. The circular RNA circPRKCI promotes tumor growth in lung adenocarcinoma. Cancer Res. 2018;78(11):2839\u201351.","journal-title":"Cancer Res"},{"issue":"4","key":"258_CR23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccell.2017.03.004","volume":"31","author":"P Hydbring","year":"2017","unstructured":"Hydbring P, Wang Y, Fassl A, Li X, Matia V, Otto T, et al. Cell-cycle-targeting MicroRNAs as therapeutic tools against refractory cancers. Cancer Cell. 2017;31(4):576\u201390 e578.","journal-title":"Cancer Cell"},{"issue":"4","key":"258_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jpha.2019.03.008","volume":"9","author":"H Rady","year":"2019","unstructured":"Rady H, Salem S, Ez E-AM. Primmorph extracts and mesohyls of marine sponges inhibit proliferation and migration of hepatocellular carcinoma cells in vitro. J Pharm Anal. 2019;9(4):284\u201391.","journal-title":"J Pharm Anal"},{"issue":"5","key":"258_CR25","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.3892\/or.2015.3812","volume":"33","author":"Q Li","year":"2015","unstructured":"Li Q, Qiu XM, Li QH, Wang XY, Li L, Xu M, et al. MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7. Oncol Rep. 2015;33(5):2354\u201360.","journal-title":"Oncol Rep"},{"issue":"1","key":"258_CR26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1186\/s12885-017-3829-9","volume":"17","author":"P Zhou","year":"2017","unstructured":"Zhou P, Wang C, Hu Z, Chen W, Qi W, Li A. Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1\/NF-kappaB\/slug\/E-cadherin pathway. BMC Cancer. 2017;17(1):813.","journal-title":"BMC Cancer"},{"key":"258_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.oraloncology.2018.03.004","volume":"80","author":"JP Joseph","year":"2018","unstructured":"Joseph JP, Harishankar MK, Pillai AA, Devi A. Hypoxia induced EMT: a review on the mechanism of tumor progression and metastasis in OSCC. Oral Oncol. 2018;80:23\u201332.","journal-title":"Oral Oncol"},{"issue":"1\u20134","key":"258_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbrc.2018.10.170","volume":"507","author":"H Dawei","year":"2018","unstructured":"Dawei H, Honggang D, Qian W. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS. Biochem Biophys Res Commun. 2018;507(1\u20134):83\u201390.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"258_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1111\/his.12668","volume":"67","author":"R Cappellesso","year":"2015","unstructured":"Cappellesso R, Marioni G, Crescenzi M, Giacomelli L, Guzzardo V, Mussato A, et al. The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and slug in laryngeal squamous cell carcinoma. Histopathology. 2015;67(4):491\u2013500.","journal-title":"Histopathology."},{"issue":"1","key":"258_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrc.2015.6","volume":"16","author":"S Seton-Rogers","year":"2016","unstructured":"Seton-Rogers S. Epithelial-mesenchymal transition: untangling EMT's functions. Nat Rev Cancer. 2016;16(1):1.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"258_CR31","first-page":"3150","volume":"8","author":"J Zhou","year":"2015","unstructured":"Zhou J, Tao D, Xu Q, Gao Z, Tang D. Expression of E-cadherin and vimentin in oral squamous cell carcinoma. Int J Clin Exp Pathol. 2015;8(3):3150\u20134.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1\u20133","key":"258_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12307-017-0201-1","volume":"10","author":"Y Ozaki-Honda","year":"2017","unstructured":"Ozaki-Honda Y, Seki S, Fujiwara M, Matsuura M, Fujita S, Ikeda H, et al. Prognostic prediction of Oral squamous cell carcinoma by E-cadherin and N-cadherin expression in overall cells in tumor nests or tumor cells at the invasive front. Cancer Microenviron. 2017;10(1\u20133):87\u201394.","journal-title":"Cancer Microenviron"},{"issue":"7","key":"258_CR33","doi-asserted-by":"publisher","first-page":"e0199442","DOI":"10.1371\/journal.pone.0199442","volume":"13","author":"R Nakamura","year":"2018","unstructured":"Nakamura R, Ishii H, Endo K, Hotta A, Fujii E, Miyazawa K, et al. Reciprocal expression of slug and snail in human oral cancer cells. PLoS One. 2018;13(7):e0199442.","journal-title":"PLoS One"},{"issue":"3","key":"258_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41419-018-0444-x","volume":"9","author":"YY Ye","year":"2018","unstructured":"Ye YY, Mei JW, Xiang SS, Li HF, Ma Q, Song XL, et al. MicroRNA-30a-5p inhibits gallbladder cancer cell proliferation, migration and metastasis by targeting E2F7. Cell Death Dis. 2018;9(3):410.","journal-title":"Cell Death Dis"}],"container-title":["Head &amp; Face Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13005-021-00258-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13005-021-00258-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13005-021-00258-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T07:06:01Z","timestamp":1614323161000},"score":1,"resource":{"primary":{"URL":"https:\/\/head-face-med.biomedcentral.com\/articles\/10.1186\/s13005-021-00258-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["258"],"URL":"https:\/\/doi.org\/10.1186\/s13005-021-00258-2","relation":{},"ISSN":["1746-160X"],"issn-type":[{"value":"1746-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]},"assertion":[{"value":"8 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors approved the publication of this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}